Boswellia and Brain Health: What Does the Research Say?
- , by SANUSq Research team
- 12 min reading time
Boswellia, the fragrant resin better known as frankincense, keeps turning up in conversations about the brain. Search "boswellia memory" and you will find bold promises about focus, recall and protecting the ageing brain. The idea is appealing, but most of the evidence comes from cells and animals, with only a handful of small human studies. Here is an honest look at what is known, what isn't, and how to think about it.
Boswellia: an ancient resin with an anti-inflammatory reputation
Boswellia is a genus of trees from India, the Horn of Africa and the Arabian Peninsula. The species most often studied as a supplement is Boswellia serrata, or Indian frankincense; Boswellia sacra and Boswellia carterii grow further west. Their resin has been burned in religious ceremonies for thousands of years and taken by mouth in traditional Indian and Arabic medicine.
The compounds that interest researchers are the boswellic acids. The best studied is AKBA (acetyl-11-keto-β-boswellic acid), which blocks an enzyme called 5-lipoxygenase, or 5-LOX. That enzyme helps the body make leukotrienes, signalling molecules involved in inflammation. This mechanism is the main reason people talk about boswellia as an anti-inflammatory plant.
Where boswellia has been tested properly in people, it has mostly been for joints rather than the brain.
In a 90-day randomised, placebo-controlled trial, Sengupta et al. (2008) gave 75 people with knee osteoarthritis either a Boswellia serrata extract enriched in AKBA (100 mg or 250 mg a day) or a placebo. Both doses were associated with significant improvements in pain and physical function scores compared with placebo, and safety measures were largely unchanged.
A systematic review and meta-analysis by Yu et al. (2020) pooled seven randomised trials involving 545 people with osteoarthritis. Boswellia and its extracts were associated with less pain and stiffness and better joint function than the comparison groups, with the authors suggesting at least four weeks of use in the trials they reviewed.
In other words, of all the Boswellia serrata benefits you may read about, the best documented is in the joints. The brain is a newer and much less certain line of research.
A long traditional history
In Ayurveda, boswellia is known as Shallaki. It has traditionally been used for joint comfort, and also for the respiratory and digestive systems. That reputation shaped modern research, which focused first on the most obvious area: inflammation. Interest has grown over the past twenty years, helped by the identification of the boswellic acids and a wider interest in plant compounds that influence inflammation.
Keeping that thread in mind helps explain the brain story. The path runs from tradition, to inflammation, and only then to the brain.
Why researchers link inflammation and the brain
Long-lasting, low-grade inflammation in the brain, often called neuroinflammation, is now thought to play a part in brain ageing and in several neurodegenerative diseases. Much of it is driven by microglia, the immune cells of the nervous system. They are useful when they respond briefly to injury or infection, but when they stay switched on for long periods they can help create an environment that puts strain on neurons.
The reasoning is straightforward: if boswellia calms inflammation elsewhere in the body, perhaps it does something similar in the brain. That is a sensible working hypothesis. It is not a conclusion.
There is one piece of biology that makes the idea plausible. In animals, boswellic acids can reach brain tissue in measurable amounts, so in theory they could act there.
In a study in mice, Hüsch et al. (2013) measured boswellic acids in the blood and in tissues, including the brain. A lecithin-based formulation produced much higher blood and tissue levels than a standard extract, including roughly 35-fold higher brain concentrations of KBA and AKBA. The authors also noted that absorption of these acids is low in both rodents and humans.
What the brain studies show: mostly animals
This is where precision matters, because shortcuts are common. The encouraging brain findings come mainly from preclinical studies, in cells and animals rather than people.
Ding et al. (2014) studied rats in which a stroke was induced in the laboratory, along with neurons grown in a dish. AKBA reduced the area of damaged brain tissue and improved neurological scores at 48 hours, and the effect appeared to depend on activating the Nrf2/HO-1 pathway, part of the cell's antioxidant defence system.
In a study of 40 male rats, Marefati et al. (2020) triggered brain inflammation with a bacterial toxin (lipopolysaccharide). Rats given AKBA beforehand performed better in two memory tests and showed lower levels of inflammatory markers and higher levels of BDNF, a protein involved in nerve cell growth, in the hippocampus.
These results are interesting and fit together reasonably well. But it needs saying plainly: what works in a rat given a laboratory injury does not automatically work in a person, and the doses and conditions are very different from everyday supplement use.
Boswellia memory studies in people: small and early
A few human trials have looked at memory or thinking. They are worth knowing about, but each has limits that stop them from settling the question.
Taghizadeh et al. (2018) randomised 70 older adults in Iran to a tablet combining Boswellia serrata and lemon balm (Melissa officinalis) or a placebo for one month. Memory scores improved more in the tablet group, but only 53 people completed the study, it was short, and because two herbs were combined the effect of boswellia alone cannot be separated out.
Salter et al. (2025) ran a 120-day placebo-controlled trial in 100 adults aged 40–65 with self-reported memory complaints, using a blend of Boswellia serrata and Terminalia chebula. The blend was associated with better scores on several memory and learning tests and was well tolerated. The authors describe it as a proof-of-concept study; it tested a combination product, and one author is employed by a company in the supplement sector.
So the human evidence is real but thin: small numbers, short durations, and mostly combination products. There are no large, independent trials showing that boswellia on its own improves memory in healthy people, or that it slows memory decline.
Proposed mechanisms: antioxidant and anti-inflammatory pathways
Beyond blocking 5-LOX, researchers describe other possible routes from laboratory work: activation of the Nrf2/HO-1 antioxidant pathway, lower levels of some inflammatory cytokines, and calmer microglia in animal models. Together these make a coherent picture at the cellular level. They explain why scientists are interested. They do not show that a supplement will protect the brain of a healthy person.
The contrast with joint research
The gap between brain and joint research is instructive. For knee osteoarthritis there are randomised, placebo-controlled trials in hundreds of patients, using standard measures of pain and function. For the brain, most of the evidence is animal models and mechanisms, plus a few small human studies of herbal blends.
That does not mean the brain research is wrong. It means it has not yet been tested with the same rigour. Treating the two as equal would present a promise as a fact.
Cautions before taking boswellia
Boswellia is generally well tolerated in trials, but a few points deserve care:
- Quality. Choose a standardised extract with a stated boswellic acid content from a transparent manufacturer, rather than resin of uncertain origin.
- Absorption. Boswellic acids are poorly absorbed, so the form and formulation can matter as much as the dose on the label.
- Stomach upset. Nausea, heartburn, diarrhoea or abdominal discomfort are the side effects most often reported. Taking it with food may help.
- Blood thinners and other medicines. Boswellia may, in theory, add to the effect of anticoagulant or antiplatelet medicines such as warfarin or aspirin, and could interact with other drugs. Speak to your doctor or pharmacist first if you take any regular medication, and stop before surgery if advised.
- Pregnancy and breastfeeding. There is not enough safety information, so avoid it unless your doctor advises otherwise.
If you or someone close to you has memory problems, confusion or changes in thinking, see your doctor rather than trying a supplement first. Memory changes have many causes, some very treatable, and they deserve a proper assessment.
Where the evidence really stands
Boswellia is an anti-inflammatory plant whose best-established human use is for the joints. Brain findings are promising but mostly preclinical. They justify more research; they do not support claims that a supplement boosts brain performance or prevents Alzheimer's disease. Poor absorption of boswellic acids is a further obstacle between laboratory results and reliable effects in people.
If you are interested in boswellia for joint comfort, the evidence is far stronger. For keeping your brain healthy, the habits with the best evidence are still the safest bet: good sleep, regular physical activity, a balanced diet, staying mentally and socially engaged, and managing stress. No supplement replaces them.
Frequently asked questions
Is boswellia good for the brain?
Brain research on boswellia is encouraging but mostly in cells and animals. In people, the best-supported use is for joint comfort. A few small human studies of herbal blends containing boswellia reported better memory scores, but it is too early to call it a brain supplement.
Does boswellia improve memory?
In rats, AKBA improved memory performance after laboratory-induced brain inflammation. In people, two small trials of boswellia combined with other herbs found better memory test scores over one to four months. Larger, independent studies of boswellia alone are still needed.
Can boswellia prevent Alzheimer's or Parkinson's disease?
There is no evidence that it can. Neuroinflammation is involved in these conditions, which is why researchers are interested, but no clinical trial shows that boswellia prevents or slows them. Anyone with concerns about these conditions should talk to their doctor.
What are boswellic acids?
They are the main active compounds in boswellia resin. The best studied, AKBA, blocks the 5-LOX enzyme involved in making inflammatory signalling molecules, which is the main basis for boswellia's anti-inflammatory reputation.
Who should not take boswellia?
People who are pregnant or breastfeeding, and anyone taking blood thinners or other regular medication, should check with a doctor first. Stop taking it if you get persistent stomach upset. It is not a substitute for medical care.
What is the difference between boswellia and turmeric?
They are different plants. Both are studied for their effects on inflammation, but through different pathways: turmeric's curcumin mainly acts on COX and NF-κB, while boswellia acts mainly on 5-LOX. Some people use them together, but neither replaces medical treatment.
Turmeric capsules from SANUSq
A plant-based turmeric supplement in vegetable capsules. It contains turmeric, not boswellia.
Free shipping available — see current offers
References
- Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Research & Therapy. 2008;10(4):R85. PMID 18667054
- Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2020;20(1):225. PMID 32680575
- Hüsch J, Bohnet J, Fricker G, et al. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome) of Boswellia extract. Fitoterapia. 2013;84:89–98. PMID 23092618
- Ding Y, Chen M, Wang M, et al. Neuroprotection by acetyl-11-keto-β-Boswellic acid, in ischemic brain injury involves the Nrf2/HO-1 defense pathway. Scientific Reports. 2014;4:7002. PMID 25384416
- Marefati N, Beheshti F, Memarpour S, et al. The effects of acetyl-11-keto-β-boswellic acid on brain cytokines and memory impairment induced by lipopolysaccharide in rats. Cytokine. 2020;131:155107. PMID 32380425
- Taghizadeh M, Maghaminejad F, Aghajani M, Rahmani M, Mahboubi M. The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: a randomized controlled trial. Archives of Gerontology and Geriatrics. 2018;75:146–150. PMID 29306113
- Salter D, Gupta SVB, Sairam B, Gupta AK, Maurya R. A standardized combination of Boswellia serrata and Terminalia chebula extracts to improve cognition in adults with subjective memory complaints: a randomized controlled proof-of-concept study. Frontiers in Nutrition. 2025;12:1695341. PMID 41438191
Read more on the blog
Watch on YouTube
Explore more on our channel, @SANUSqHealthSupplements.
We wish you good health on your terms.
The team at SANUSq.
PS. Curious what's currently on offer? Take a look at our latest promotions.
The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.
Regulatory Notice
The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.